Abstract
Background The Kadutu Health Zone (HZK) in Bukavu, located in the east of the Democratic Republic of Congo, is one of the areas most affected by cholera. This study aims to identify the factors explaining the occurrence of cholera epidemics in this region.
Methods A case-control study was conducted between January and June 2024, with a sample drawn from cholera cases of the 2023 outbreak. A questionnaire was administered to 112 cases and 224 controls. Data were analyzed using SPSS v 25 software.
Results The results revealed nine factors significantly associated with the onset of the epidemic: low monthly income (OR = 2.49; p = 0.010), non-washing of hands before eating (OR = 25.85; p < 0.001) and before breastfeeding (OR = 3.06; p = 0.006), lack of hygiene of soiled hands (OR = 19.37; p < 0.001), defecation outside the toilet (OR = 4.54; p < 0.001), recourse to traditional practitioners (OR = 3.28; p = 0.033), lack of toilets (OR = 2.07; p = 0.017), and lack of knowledge of the modes of transmission (OR = 2.94; p = 0.032) and prevention (OR = 1.75; p = 0.037).
Conclusion Cholera prevention in the HZK requires a multisectoral approach, taking into account sociodemographic, economic, environmental, cultural and health factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research protocol was submitted to the ethics committee of the Kinshasa School of Public Health (ESPK) and received its approval under N°. ESP/CE/189/2023. This study was conducted in strict compliance with the main ethical principles which are: respect for the person (autonomy and self-determination), and benevolence in justice.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.